Abstract
Background
To compare the surgical outcomes and evaluate the effectiveness of two treatments for central retinal vein occlusion (CRVO), radial optic neurotomy (RON) and intravitreal triamcinolone (IVT), in comparison to natural history.
Methods
A prospective, placebo-controlled, randomised and multi-center study. Patients with CRVO were treated in three groups — with either RON, a single intravitreal injection of 4 mg triamcinolone acetonide, or a placebo treatment. The main outcome measures were change of VA (visual acuity) and proportion of eyes with a significant improvement (defined as >3 lines logMAR scale) of VA from baseline to month 12.
Results
Ninety patients were included. Due to insufficient data, seven were excluded. Forty-seven percent (n = 18) of patients treated with RON showed an increase in VA, in comparison to 10 % (n = 2) of placebo-treated patients, and 20 % (n = 5) of patients treated with IVT. Significantly more patients showed an improvement in VA following RON than in the placebo group (p = 0.009). Significantly more patients showed an improvement in VA following RON than in the IVT group (p = 0.034). No significant difference was found when directly comparing improvement in VA following IVT and placebo (p = 0.667) treatment.Significantly (p = 0.007) more patients in the placebo group (35 %, n = 7) showed a deterioration (defined as > 3 lines LogMAR scale) in VA than patients in the RON group (8 %, n = 3).
Conclusion
Our study showed that following treatment with RON, patients with CRVO display a significantly better long-term VA than untreated patients and patients treated with a single dose of IVT.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-012-2134-1/MediaObjects/417_2012_2134_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-012-2134-1/MediaObjects/417_2012_2134_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-012-2134-1/MediaObjects/417_2012_2134_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-012-2134-1/MediaObjects/417_2012_2134_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-012-2134-1/MediaObjects/417_2012_2134_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-012-2134-1/MediaObjects/417_2012_2134_Fig6_HTML.gif)
Similar content being viewed by others
References
International Eye Disease Consortium. Collaborators, Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY (2010) The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117(2):313–319, e1
Gutman FA (1983) Evaluation of a patient with central retinal vein occlusion. Ophthalmology 90:481–483
Guven D, Sayinalp N, Kalayci D, Dundar S, Hasiripi H (1999) Risk factors in central retinal vein occlusion and activated protein C resistance. Eur J Ophthalmol 9:43–48
Green WR, Chan CC, Hutchins GM, Terry JM (1981) Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 79:371–422
Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ (2001) Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 21:408–415
Aggermann T, Brunner S, Binder S (2003) Therapien retinaler Venenverschlüsse — ein Überblick. Spektrum der Augenheilkunde 17:200–205
Cooney MJ, Fekrat S, Finkelstein D (1998) Current concepts in the management of central retinal vein occlusion. Curr Opin Ophthalmol 9:47–50
Central Vein Occlusion Study Group (1995) Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 102:1425–1433
Burggraaff MC, van Nispen RM, Hoek S, Knol DL, van Rens GH (2010) Feasibility of the Radner Reading Charts in low-vision patients. Graefes Arch Clin Exp Ophthalmol 248(11):1631–1637
Holladay JT (1997) Proper method for calculating average VA. J Refract Surg 13:388–391
Hayreh SS (2003) Management of central retinal vein occlusion. Ophthalmologica 217:167–188
Central Vein Occlusion Study Group (1993) Baseline and early natural history report. Arch Ophthalmol 111:1087–1095
Magargal LE, Donoso LA, Sanborn GE (1982) Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology 89:1241–1245
Binder S, Brunner S, Abri A, Glittenberg C (2003) Radiäre Neurotomie des Nervus Opticus — Erste Ergebnisse. Spektrum der Augenheilkunde 17:206–211
Nishimura A, Kobayashi A, Segawa Y et al (2003) Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter. Retina 23:777–779
Jonas JB, Kreissig I, Degenring R (2003) Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87(1):24–27
Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH, SCORE Study Research Group (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 127(9):1101–1114
Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Trieschmann M, Pauleikhoff D (2007) Radial optic neurotomy for ischemic central retinal vein occlusion. Klin Monatsbl Augenheilkd 224(10):763–769
Binder S, Aggermann T, Brunner S (2007) Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series. Graefes Arch Clin Exp Ophthalmol 245(10):1447–1452
Arevalo JF, Garcia RA, Wu L, Rodriguez FJ, Dalma-Weiszhausz J, Quiroz-Mercado H, Morales-Canton V, Roca JA, Berrocal MH, Graue-Wiechers F, Robledo V, Pan-American Collaborative Retina Study Group (2008) Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES). Retina 28(8):1044–1052
Callizo J, Kroll P, Mennel S, Schmidt JC, Meyer CH (2009) Radial optic neurotomy for central retinal vein occlusion: long-term retinal perfusion outcome. Ophthalmologica 223(5):313–319
Fortunato P, Pollazzi L, Baroni M, Evangelisti A, La Torre A (2010) Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 248(2):167–173
Nomoto H, Shiraga F, Yamaji H, Kageyama M, Takenaka H, Baba T, Tsuchida Y (2004) Evaluation of radial optic neurotomy for central retinal vein occlusion by indocyanine green videoangiography and image analysis. Am J Ophthalmol 138:612–619
Weizer JS, Stinnett SS, Fekrat S (2003) Radial optic neurotomy as treatment for central retinal vein occlusion. Am J Ophthalmol 136:814–819
Garciia-Arumii J, Boixadera A, Martinez-Castillo V, Castillo R, Dou A, Corcostegui B (2003) Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol 121:1385–1391
Williamson TH, Poon W, Whitefield L, Strothidis N, Jaycock P, Strothoudis N (2003) A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol 87:1126–1129
Friedman SM (2003) Optociliary venous anastomosis after radial optic neurotomy for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 34:315–317
McAllister IL, Douglas JP, Constable IJ, Yu DY (1998) Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 126:219–229
Hsu J, Kaiser RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, Vander JF, Regillo CD, Ho AC (2007) Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina 27(8):1013–1019
Rouvas A, Petrou P, Vergados I, Pechtasides D, Liarakos V, Mitsopoulou M, Ladas I (2009) Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study. Graefes Arch Clin Exp Ophthalmol 247(12):1609–1616
Wroblewski JJ, Wells JA 3rd, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM (2009) Pegaptanib in Central Retinal Vein Occlusion Study Group (2009) Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol 127(4):374–380
Acknowledgments
The authors thank the principal investigators in The ROVO Study Group:
Prof. Dr. Michel Eid Farah — Universidade Federal de São Paulo, Brazil
Prof. Dr. Vito Belloli — Ospedale S.S. Trinità di Arona, Italy
Prof. Dr. António Travassos — Centro Cirúrgico de Coimbra, Portugal
Prof. Dr. Marta Suárez de Figueroa — Ramón y Cajal University Hospital, Spain
Prof. Dr. José Garcia-Arumi — Instituto de Microcirugía Ocular, Spain
Prof. Dr. Tarapasad Das — LV Prasad Eye Institute, India
The authors also thank the entire staff of all participating centers and all helpers who contributed towards this study, especially Prof. Dr. Wolfgang Radner, Prof. Dr. Peter Bauer, Prof. Dr. Siamak Ansari Shahrezaei, Ms. Astrid Kürsten and the entire staff of the Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Vienna, Austria.
The study was financed by a grant from the Jubiläumsfonds der Österreichischen Nationalbank (OeNB)) /Austrian National Bank, as well as by the Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Vienna, Austria.
The authors have no commercial connection or financial interest that is related to the manuscript. The authors have full control of all primary data, and agree to allow Graefe's Archive for Clinical and Experimental Ophthalmology to review their data upon request.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
The ROVO Study Group:
Prof. Dr. Susanne Binder - Rudolph Foundation Hospital, Austria Prof. Dr. Michel Eid Farah — Universidade Federal de São Paulo, Brazil Prof. Dr. Vito Belloli — Ospedale S.S. Trinità di Arona, Italy Prof. Dr. António Travassos — Centro Cirúrgico de Coimbra, Portugal Prof. Dr. Marta Suárez de Figueroa — Ramón y Cajal University Hospital, Spain Prof. Dr. José Garcia-Arumi — Instituto de Microcirugía Ocular, Spain Prof. Dr. Tarapasad Das — LV Prasad Eye Institute, India
Clinical trial registration
EK-04-010-0204 NCT00532142 http://www.clinicaltrials.gov
Rights and permissions
About this article
Cite this article
Aggermann, T., Brunner, S., Krebs, I. et al. A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group. Graefes Arch Clin Exp Ophthalmol 251, 1065–1072 (2013). https://doi.org/10.1007/s00417-012-2134-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2134-1